CRISPRMED26 - The 3rd CRISPR MEDiCiNE Conference 2026, April 13th - 16th, Copenhagen, Denmark

Join the Global CRISPR MEDiCiNE Community in Copenhagen - April 14^th - 16^th 2026 (Satellite Meetings April 13^th)

The 3^rd edition of the CRISPR MEDiCiNE Conference will take place in Copenhagen, Denmark from April 13^th - 16^th 2026.

This premier annual event shines a spotlight on critical breakthroughs and challenges in CRISPR medicine - from cutting-edge tools and delivery systems to safety, regulation, functional genomics, pre-clinical pipelines, and advances in clinical trials.

Expect:

• World-class speakers from academia, biotech and industry

• Skill-building workshops to accelerate your career

• Live poster sessions (virtual and on-site) to showcase your work

New for 2026: Satellite Meetings built to spark collaboration between stakeholders, networks, and communities across Europe working in the genomic medicine field.

Submit your abstract for a chance to be selected for an oral presentation - or even featured in CRISPR Medicine News, read by 35,000+ professionals monthly.

Ready to join?

Why You Should Attend CRISPRMED26

• Stay at the Cutting Edge of Gene Editing - Gain the latest insights on CRISPR tools, functional genomics platforms, delivery strategies, in vivo editing, clinical progress, and AI-driven therapeutic development.

• Learn from Global Leaders - Engage directly with top researchers, clinicians, biotech innovators, regulators, and patient advocates shaping genomic medicine.

• Explore Real-World Applications & Regulations - Understand how CRISPR is translated into therapies and navigate CMC, pre-clinical, and clinical pathways with expert guidance.

• Advance Your Career & Skills - Participate in technical workshops, communication challenges, and job-matching sessions to grow professionally.

• Connect & Collaborate - Network with 400+ participants, join flash talks, satellite meetings, and founders’ circles to build valuable collaborations.

• Experience a Dynamic Format - Take part in interactive panels, social events, and virtual sessions to stay connected and engaged.

Questions? Check out our FAQ section or contact CRISPRMED26 staff at support@crisprmedicineconference.com.

Want to be updated on CRISPRMED26's latest news?

Scientific Committee

• Özcan Met, PhD, Ass. Prof. and Head of Cell Therapy Unit and DTU HealthTech, CCIT-DK / DTU, Denmark.

• Jakob Nilsson, Prof. and Group leader, Danish Cancer Institute, Denmark.

• Cecilia Jimenez-Mallebrera, PhD and Research Director, Institut de Recerca Sant Joan de Déu. Hospital Sant Joan de Déu Barcelona and CIBERER, Spain.

• Laura Torella, PostDoc, AstraZeneca, Sweden.

• Alessia Cavazza, Ass. Prof. and Group leader, Zayed Centre for Research into Rare Diseases in Children, UCL Great Ormond Street Institute of Child Health, University College London, UK.

Organising Committee

• Gorm Palmgren, Chief Editor, CRISPR Medicine News

• Clarissa Braun, Communications and Project Manager, CRISPR Medicine News

• Antonio Carusillo, Science Communication Officer, CRISPR Medicine News

• Manel Lladó, Science Communication Officer, CRISPR Medicine News

• Martina Franchini, Science Communication Officer, CRISPR Medicine News

• Martina Tarozzi, Consultant, CRISPR Medicine News

• Jens-Ole Bock, Founder, CRISPR Medicine News/ CRISPRMED Conferences

Abstract Reviewers

• Özcan Met, PhD, Ass. Prof. and Head of Cell Therapy Unit and DTU HealthTech, CCIT-DK / DTU, Denmark.

• Jakob Nilsson, Prof. and Group leader, Danish Cancer Institute, Denmark.

• Cecilia Jimenez-Mallebrera, PhD and Research Director, Institut de Recerca Sant Joan de Déu. Hospital Sant Joan de Déu Barcelona and CIBERER, Spain.

• Laura Torella, PostDoc, AstraZeneca, Sweden.

• Alessia Cavazza, Ass. Prof. and Group leader, Zayed Centre for Research into Rare Diseases in Children, UCL Great Ormond Street Institute of Child Health, University College London, UK.

• Karim Benabdel Lah El Khlanji, Senior Scientist at the GENyO Pfizer-University of Granada-Junta de Andalucia Center for Genomics and Oncological Research in Granada, Spain, GeneHumdi Action Chair.

• Jan Gorodkin, Professor and Group Leader at the University of Copenhagen, Denmark.

• Julian Grünewald, Assistant Professor and Emmy Noether group leader at Technical University of Munich, Germany.

• Dr. Carla Fuster, University of Freiburg, Germany

• Anastasia Conti, Postdoc, Project Leader, San Raffaele Telethon Institute for Gene Therapy (SR-TIGET), Milan, Italy.

• Antonio Carusillo, PhD, Senior Postdoctoral Fellow at Fondazione Telethon, Italy, and Science Communication Officer, CRISPR Medicine News.